Avantax Advisory Services’s Innoviva INVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$435K Buy
21,633
+1,123
+5% +$21.6K ﹤0.01% 1671
2025
Q1
$372K Buy
20,510
+2,009
+11% +$36K ﹤0.01% 1692
2024
Q4
$321K Buy
18,501
+1,381
+8% +$26.5K ﹤0.01% 1737
2024
Q3
$331K Sell
17,120
-51
-0.3% -$940 ﹤0.01% 1685
2024
Q2
$282K Buy
17,171
+758
+5% +$11.8K ﹤0.01% 1736
2024
Q1
$250K Buy
16,413
+3,996
+32% +$62.8K ﹤0.01% 1409
2023
Q4
$199K Buy
12,417
+1,907
+18% +$26.7K ﹤0.01% 1478
2023
Q3
$137K Buy
+10,510
New +$136K ﹤0.01% 1471

Other funds holding INVA

Avantax Advisory Services's INVA Position: Q2 2025 in Review

Avantax Advisory Services increased its Innoviva (INVA) stake by 5.5% in Q2 2025, buying an estimated $21.6K and bringing the position to 21,633 shares worth $435K. The position accounts for ﹤0.01% of the portfolio, ranked #1671.

Avantax Advisory Services first reported a position in INVA in Q3 2023 and has held it in 8 quarters since. 266 funds tracked by Wall St. Rank hold INVA as of Q2 2025.

  • Avantax Advisory Services held 21,633 shares of Innoviva worth $435K as of Q2 2025.
  • Avantax Advisory Services bought 1,123 Innoviva shares in Q2 2025, an estimated $21.6K.
  • Innoviva made up ﹤0.01% of Avantax Advisory Services's portfolio in Q2 2025, its #1671 holding.
  • Avantax Advisory Services first reported a position in Innoviva in Q3 2023 and has held it in 8 quarters since.
  • 266 funds tracked by Wall St. Rank held Innoviva as of Q2 2025.

Based on Avantax Advisory Services's 13F filing for Q2 2025, filed 8 Aug 2025.